Biological effectiveness of antiproton annihilation

We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in “biological dose” in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct meas...

Full description

Saved in:
Bibliographic Details
Published inNuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms Vol. 221; pp. 210 - 214
Main Authors Holzscheiter, Michael H., Agazaryan, Nzhde, Bassler, Niels, Beyer, Gerd, DeMarco, John J., Doser, Michael, Ichioka, Toshiyasu, Iwamoto, Keisuke S., Knudsen, Helge V., Landua, Rolf, Maggiore, Carl, McBride, William H., Møller, Søren Pape, Petersen, Jorgen, Smathers, James B., Skarsgard, Lloyd D., Solberg, Timothy D., Uggerhøj, Ulrik I., Withers, H.Rodney, Vranjes, Sanja, Wong, Michelle, Wouters, Bradly G.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.07.2004
Subjects
Antiproton annihilation
Biological response
Bragg peak
Bragg peak
25.43
87.53
87.50
Biological response
Antiproton annihilation
Online AccessGet full text

Cover

More Information
Summary:We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in “biological dose” in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The experiment has been approved by the CERN Research Board for running at the CERN Antiproton Decelerator (AD) as AD-4/ACE (Antiproton Cell Experiment) and has begun data taking in June of 2003. The background, description and the current status of the experiment are given.
ISSN:0168-583X
1872-9584
DOI:10.1016/j.nimb.2004.03.057